Multimodal treatment of hepatocellular carcinoma (HCC).

  title={Multimodal treatment of hepatocellular carcinoma (HCC).},
  author={J{\"o}rg W. Sturm and Michael A. Keese},
  volume={27 3},
Screening of patients at risk for hepatocellular carcinomas (HCC) and preventive virustatic therapy are the first steps in a multimodal treatment concept, because delayed detection leads to a poor prognosis with median survival of <10 months. Surgical resection of HCC is still the treatment of choice in patients with good residual liver function, however, recurrence-free 5-year survival after curative resection is low (33%). In patients with cirrhosis, only 25% of HCC are resectable, limited by… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…